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Abstract
Background: Metabolic syndrome (MS) is a clustering of cardiometabolic risk factors that is considered a predictor
of cardiovascular disease, type 2 diabetes and mortality. There is no consistent evidence on whether the MS
construct works in the same way in different populations and at different stages in life.
Methods: We used confirmatory factor analysis to examine if a single-factor-model including waist circumference,
triglycerides/HDL-c, insulin and mean arterial pressure underlies metabolic syndrome from the childhood to
adolescence in a 6-years follow-up study in 174 Swedish and 460 Estonian children aged 9 years at baseline.
Indeed, we analyze the tracking of a previously validated MS index over this 6-years period.
Results: The estimates of goodness-of-fit for the single-factor-model underlying MS were acceptable both in
children and adolescents. The construct stability of a new model including the differences from baseline to the
end of the follow-up in the components of the proposed model displayed good fit indexes for the change,
supporting the hypothesis of a single factor underlying MS component trends.
Conclusions: A single-factor-model underlying MS is stable across the puberty in both Estonian and Swedish
young people. The MS index tracks acceptably from childhood to adolescence.
Keywords: Tracking, Metabolic syndrome, Confirmatory factor analysis
Background
Metabolic syndrome (MS) is a clustering of cardiometa-
bolic risk factors, and is considered a predictor of cardi-
ovascular disease, type 2 diabetes and mortality [1]. The
definition of MS is controversial, but it generally
includes insulin resistance or glucose intolerance, hyper-
tension, dyslipidemia and central obesity [2,3].
A number of studies have examined the relationships
among the cardiometabolic risk factors included in the
MS definition by using exploratory [4,5] or confirmatory
factorial analysis (CFA) [6]. Recent studies using CFA
suggested that a single factor underlies the MS in chil-
dren [7] and adolescents [8], as well as in adults [9].
There is no consistent evidence on whether the MS
construct works in the same way in different popula-
tions and at different stages in life. Particularly, it would
be of interest to know to what extent the clustering of
cardiometabolic risk factors as well as the MS construct
track from childhood to adolescence. A recent review
identified seven studies that investigated the stability of
the clustering of cardiometabolic risk factors from child-
hood to adolescence [10]. Most of the studies focused
the analyses only on the tracking of the clustering of
cardiometabolic risk factors [11] and a few of them also
studied the stability over time of a MS composite risk
score [12-14]. However, none of them studied the stabi-
lity of the factorial structure of the MS. One study
focused on the stability from childhood to adolescence
of factorial structure of MS [15], and did not observe an
adequate fit of the proposed models at baseline; there-
fore further longitudinal analyses were not possible.
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posed [7] single factor model underlying metabolic syn-
drome in Swedish and Estonian children and
adolescents, which included waist circumference, trigly-
cerides-to-high density lipoprotein cholesterol (HDL-c)
ratio, insulin, and mean arterial pressure (MAP) (cross-
sectional study); 2) to examine, whether there is an
underlying single factor for the change in cardiometa-
bolic risk factors (i.e. factorial stability of MS) from
childhood to adolescence (6-year follow up study); and
3) to examine the tracking of the proposed MS index
[7] from the puberty to the adolescence controlling for
relevant confounders.
Methods
Study sample and design
Estonian and Swedish participants were originally (in
1998/9, baseline) part of the European Youth Heart
S t u d y( E Y H S ) .S t u d yd e s i g n ,s e l e c t i o nc r i t e r i aa n ds a m -
ple calculations have been reported elsewhere [16]. In
2004/5 (follow-up), participants were invited to com-
plete the same examination as in 1998/9; the median
(percentile 25
th -7 5
th) follow-up period was 5.97 years
(5.73-6.00). Measurements at baseline and follow-up
were made by essentially the same group of trained
investigators, and by using the same protocols, which
allows performing combined analyses. The follow-up
assessment in the Estonian cohort was carried out as
part of the longitudinal Estonian Children Personality
Behaviour and Health Study [17]. The study design is
graphically depicted in Figure 1.
For the study purposes, participants with complete
and valid data at baseline on waist circumference, trigly-
cerides, HDL-c, insulin and systolic and diastolic blood
pressure were included in the cross-sectional analyses
(Aim 1, baseline examination 1998/9): N = 1158 Esto-
nian children (9 year-old, N = 565) and adolescents (15
year-old, N = 593), and N = 906 Swedish children (9
year-old, N = 440) and adolescents (15 year-old, N =
466). Six years later, the children cohort was invited to
participate in the follow-up examination. A total of 460
Estonian (dropout rate = 19%) and 174 Swedish (drop-
out rate = 60%) children with valid data on all the vari-
ables mentioned above were included in the study (Aim
2 and 3). There were no significant difference between
participants and non-participants in the follow-up stu-
dies regarding the main study outcomes, i.e. waist cir-
cumference, triglycerides, HDL-c, insulin and blood
pressure (all p > 0.1). Higher maternal education was
however associated to higher participation rate at fol-
low-up (p < 0.001).
The study protocol was performed in accordance with
the ethical standards laid down in the 1961 Declaration
of Helsinki (as revised in 2000), and approved by the
Research Ethics Committees of University of Tartu (no.
49/30-199), Örebro County Council (no. 690/98) and
Huddinge University Hospital (no. 474/98). Children
and adolescents gave verbal assent after procedures
were explained and one parent or legal guardian pro-
vided written informed consent.
Central body fat
Waist circumference was taken with a metal anthropo-
metric tape midway between the lower rib margin and
the iliac crest, at the end of gentle expiration in tripli-
cate, and the mean was scored [18]. Waist circumfer-
ence was used as proxy of central adiposity.
Blood parameters
Blood samples were taken by venipuncture after an
overnight fast. The fasting state was verbally confirmed
by the participants before sampling. HDL-c, triglycer-
ides, glucose and insulin levels were measured as
reported elsewhere [19].
Blood pressure
Systolic and diastolic blood pressure was measured with
an automatic oscillometric method (Dinamap model XL
critikron, Imc., Tampa, Florida) using standard proce-
dures described elsewhere [20]. The mean arterial pres-
sure (MAP) was calculated as follows: diastolic pressure
+ [0.333 × (systolic blood pressure - diastolic pressure)].
Metabolic syndrome index. We constructed a meta-
bolic syndrome index as the sum of the standardized
scores of the four variables that comprised our proposed
model multiplied by the factor loadings in the model
described in Spanish children [7].
Confounders
Several variables potentially related to cardiometabolic
risk factors were taken into account. Socioeconomic sta-
tus was assessed via questionnaire and defined by the
maternal educational level, coded as 0 (below university
Figure 1 Study design and aims of the present study.
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was assessed by a trained researcher by direct observa-
tion and according to Tanner and Whitehouse [21].
Birth weight data were collected from parental recall.
The validity of parents-reported birth weight data has
been previously verified in a randomly selected subset of
the Swedish-EYHS [22].
Cardiorespiratory fitness (VO2 ml/kg/min) was esti-
mated by an incremental maximal cycle-ergometer test
(Monark 829E Ergomedic, Vansbro, Sweden) as detailed
elsewhere [23].
Statistical analysis
Triglyceride-to-HDL-c ratio and insulin were log trans-
formed in the two samples to adhere to the normality
assumptions. Two main set of analyses were conducted
on 1) cross-sectional data (Aim 1), and 2) longitudinal
data (Aims 2 and 3).
Aim 1
The first step was to validate the single factor model
underlying MS suggested [7] in the present sample of
Estonian and Swedish youth. All the variables were z
transformed (mean = 0 and SD = 1) by age and sex.
CFA was used to calculate the factor loadings of the
cardiometabolic risk factors in the main model, as
well as by age and gender groups. Factors loadings
are interpreted as correlation coefficients, and mea-
sure the strength of the association between the
model variables and their overall underlying factor,
which is the MS construct itself. Factor loadings were
estimated by maximum likelihood methods with the
IBM SPSS Amos 19.0. The analyses were performed
separately by country, sex and age group (9/15 years).
Chi-squared tests were used to examine differences in
factors loadings between country, sex, and age
groups.
To assess each model’s goodness-of-fit to the observed
data, we used the chi-squared test, the comparative fit
index (CFI), and the standardized root mean square
residual (SRMR). Given that the study sample size was
relatively large, it is relatively easy for the chi-squared
test to show a significant (p < 0.05) lack of fit, so that
the results of this test cannot be assessed in isolation. A
model was deemed to have a good fit when the CFI was
> 0.96 and the SRMR was < 0.08.
Aim 2
The stability of the factorial structure of the proposed
model was assessed in two ways: (i) estimating CFA
indexes of goodness of fit in the 1998/9 cohort (at base-
line), and in the 2004/5 cohort (6-year follow up); and
(ii) estimating CFA indexes of goodness of fit of a
model including the changes from 1998/9 to 2004/5 in
waist circumference, triglyceride-to-HDL-c ratio, insulin
and MAP.
Aim 3
Pearson correlation was used to examine the tracking
(stability) of the study cardiometabolic risk factors
(waist circumference, log triglyceride-to-HDL-c ratio,
log insulin, and MAP), as well as the MS index from
childhood (baseline 1998/9) to adolescence (follow up
2004/5). A correlation ranging from 0.25 to 0.50 indi-
cates a fair relationship, a correlation from 0.50 to 0.75
indicates a moderate to good relationship, and a correla-
tion > 0.75 indicates a very good relationship [24]. The
stability was also estimated through the intraclass corre-
lation coefficient. Analyses were performed by country
and sex. The predictive validity of the persistence in the
upper quartile of cardiometabolic risk factors and MS
index in the same period time was studied by non con-
ditional binary logistic regression models. Odds ratios
were estimated with and without controlling for birth
weight, maternal education, and changes 1998-2004 in
both Tanner stage and cardiorespiratory fitness.
Results
Participant characteristics of the children and adoles-
cents have been described elsewhere [25]. The children
participating in the longitudinal study were at early pub-
erty at baseline (80.7% for Tanner stage I) and at late
puberty six years later at follow-up (69% at Tanner
stage 4 or 5).
Factorial structure of the proposed model (Aim 1)
The estimates of goodness of fit for the single factor
CFA model proposed in the present study for the total
sample were adequate (Figure 2). The overall estimates
of factor loadings were 0.36, 0.43, 0.59, and 0.30 for
waist circumference, triglyceride-to-HDL-c ratio, insulin
and MAP, respectively. All standardized fit indices sug-
gested high goodness of fit of the proposed factor struc-
ture and supported the MS measurement model (c
2 =
10.87, df = 2, p = 0.004, CFI = 0.97, and SRMR =
0.0198). The goodness of fit indices for the Estonian and
Swedish cohort were as follow: c
2 =3 . 7 0 ,d f=2 ,p=
0.159; CFI = 0.99; and SRMR = 0.016; and c
2 =3 7 . 4 ,d f
=2 ,p=0 . 0 0 1 ;C F I=0 . 9 6 ;a n dS R M R=0 . 0 5 ,r e s p e c -
tively. There were no differences in the MS structure
between countries (c
2diff = 1.2, df = 3, p = 0.753). Simi-
larly, there were no differences between boys and girls
(c
2diff = 2.0, df = 3, p = 0.572), or between children and
adolescents (c
2diff = 6.9, df = 3, p = 0.075) (Additional
file 1).
Stability of the model from puberty to adolescence (Aim
2)
Figure 3 depicts the analysis of the stability of the fac-
torial structure of MS in the participants included in the
follow up study. The estimates of goodness of fit for the
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line and after six years follow up. We also assessed the
stability of the construct testing a model including the
differences between 1998/9 and 2004/5 in the studied
cardiometabolic risk factors (i.e. waist circumference, tri-
glyceride-to-HDL-c ratio, insulin and MAP). This one-
factor model displayed good fit indexes for the change,
supporting the hypothesis that a single factor underlying
trends in MS components.
Tracking analyses
Pearson correlation coefficients showing the association
between cardiometabolic risk factors at baseline and at
follow-up were moderate to high except for insulin that
was low (Table 1). Correlations coefficients were higher
for waist circumference. Overall, no remarkable differ-
e n c e sb ys e xo rb yc o u n t r yw e r ef o u n d .T h es t r e n g t ho f
the relationship between values for MS index from 1998
to 2004 was also moderate.
The concordance between childhood and adoles-
cence of the z scores of the cardiometabolic risk vari-
ables measured by the intraclass correlation
coefficient showed a similar pattern to the inter-age
correlation coefficients (Additional file 2). The 1998-
2004 concordance of the values of the MS index was
moderate, and similar to the variables that included in
the index.
Table 2 presents the odds ratios for persistence in the
upper quartile of cardiometabolic risk factors and MS
index from childhood to adolescence in Estonia and
Sweden. The pattern of predictability was similar in
both, Estonian and Swedish samples. The risk of
remaining in the upper quartile of MS index from child-
hood to adolescence was twofold compared to children
remaining in the other categories.
Discussion
Three main findings are derived from this study. First,
the present data support the validity of a single factor
model underlying MS in Estonian and Swedish children
and adolescent, as it was previously observed in Spanish
children [7]. Second, the model structure was stable
from childhood to adolescence, i.e. the changes from 9 y
to 15 y in the model’s components fitted as a single fac-
tor. Third, we found that the cardiometabolic risk fac-
tors clustering and the MS index itself showed a good
tracking and predictability from childhood to
adolescence.
Several studies have examined the relationship among
the several traits included on MS using exploratory fac-
tor analysis. The number of described factors underlying
MS ranges from 1 to 4 [4,9], possibly due to the proper
features of this type of analysis [9]. In our previous
study conducted in Spanish children [7], we observed
one single factor for the model including waist circum-
ference, triglyceride-to-HDL-c ratio, insulin and MAP.
The present study confirms the structural validity of this
one-factor model in all the groups studied, i.e. children
and adolescents, boys and girls and Swedish and
Estonian.
Goodman et al, using data from the Fels Longitudinal
Study [15] investigated the stability of factor structure of
MS across pubertal development using CFA, but its data
did not support the hypothesis neither that a single fac-
tor nor multiple factors underlying MS already at base-
line, not allowing therefore further longitudinal analyses.
Two complementary analyses support the stability of
MS as a single factor model from childhood to adoles-
cence: first, no significant differences were found
Figure 2 Factor loading and goodness-of-fit indexes of a single
factor models for the metabolic syndrome. Total sample: n =
2064; c
2 = 10.87, df = 2, p = 0.004; CFI = 0.97; and SRMR = 0.019.
Estonian sample: n = 1158; c
2 = 3.70, df = 2, p = 0.159; CFI = 0.99;
and SRMR = 0.016. Swedish sample: n = 906; c
2 = 37.4, df = 2, p =
0.001; CFI = 0.96; and SRMR = 0.051. MAP: mean arterial pressure.
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cence, and second, a model including the differences on
each variable before and after the puberty also fits as a
single factor.
There is consistent evidence about the tracking of
every cardiometabolic risk factor integrating MS. How-
ever, the number of studies focused to examine the sta-
bility and predictability of cardiometabolic risk factor
clustering is limited [10], and only a few have analyzed
the tracking of MS as a composite quantitative index
[12,14]. Our study confirmed the stability of cardiometa-
bolic risk factors across the puberty, though the magni-
tude of this stability differs substantially among the
different variables.
A joint statement from the American Diabetes Asso-
ciation and the European Association for the Study of
Diabetes recommends expanding the evidence regarding
the use of scales based on continuous variables to mea-
sure metabolic risk [26]. In the same way, a WHO
Expert Consultation Group [27] has pointed out as lim-
itation for the clinical usefulness of the construct MS
the dichotomization of its diagnosis and the risk factors
to define MS. Furthermore, the summative scales pro-
posed until now assume that each factor has associated
the same risk, and there is no evidence to support this
assumption. The MS index is an outcome of the single
factor model fitting, and have been validated previously
[7]. The findings from the present study strengthen the
Figure 3 Goodness of fit and stability of the MetS factorial structure (A) at baseline, (B) after 6 yr follow up, and (C) including as
components the change in the variables from 1998 to 2005. A: n = 634; c
2 = 5.6, df = 2, p = 0.06; CFI = 0.98; and SRMR = 0.026. B: n =
634; c
2 = 6.7, df = 2, p = 0.03; CFI = 0.97; and SRMR = 0.027. C: n = 634 c
2 = 0.32, df = 2, p = 0.85; CFI = 0.1; and SRMR = 0.006. MAP: mean
arterial pressure.
Table 1 Pearson correlation coefficients between cardiometabolic risk variables and metabolic syndrome index from
childhood (9 year-old) to adolescence (15 year-old) by gender and by country
Variable Estonia Sweden Total
Boys (n = 222) Girls (n = 261) Boys (n = 130) Girls (n = 148) Boys (n = 352) Girls (n = 409)
Waist 0.683 0.729 0.746 0.602 0.685 0.669
log TG/HDL-c 0.360 0.368 0.472 0.392 0.381 0.375
log insulin 0.221 0.142 0.287 0.202 0.318 0.227
MAP 0.418 0.361 0.410 0.452 0.400 0.398
MS index 0.389 0.399 0.535 0.308 0.431 0.379
The European Youth Heart Study, 1998-2004.
Abbreviations: log TG/HDL: log triglyceride-to-HDL-cholesterol ratio; MAP: mean arterial pressure; MS: metabolic syndrome.
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of tracking from childhood to adolescence.
The present study has several limitations. The dropout
rates in the Swedish sample were high. However, the
construct validity of a model using CFA does not
require representativeness of the study sample. In addi-
tion, the sample size used in the longitudinal analyses
was far larger than needed for CFA [28].
Secondly, most of our analyses have been performed
in a mixed Swedish and Estonian sample, and we are
conscious that no objective analysis of MS it’s possible
without connecting it to a well-defined population or
ethnicity; for example, differences in the prevalence of
cardiometabolic risk factors between descent of Turkish
and Moroccan have been described in Dutch cohort of
overweight/obesity children [29]. In the same way,
increased triglyceride and low HDL-c levels have been
found the most frequent components of MS in Qatari
children [30], or surprisingly a follow up study in the
Seychelles have described that elevated total cholesterol
tended to decreased whereas the prevalence of MS
increased significantly [31]. However, this concern may
be not too relevant in our study in light of when we
analyzed the factorial structure of MS separately in the
Swedish and Estonian samples the coefficients were very
similar in both models (Figure 2).
Theoretically, when a factorial model of MS is
assessed by CFA, a specific model has to be chosen out
of a number of alternative models. Our single factor
model is based on an earlier validation study, and its
components are risk factors included in most of the cur-
rent diagnosis criteria of MS.
We believe that the results of the present study have
important clinical implications, due to the fact that it
supports the hypothesis that MS is a single pathogenic
e n t i t y .I tp r o v i d e se v i d e n c ea b o u tt h em o r ee f f i c i e n t
strategies for prevention and control of MS may be
those (i.e. promotion physical activity) that influence the
whole clustering of risk factors; therefore, do not sup-
port strategies focused on individualized approaches of
each risk factor component of MS, as has been proposed
[15]. Moreover, and considering the stability of the car-
diometabolic risk factors levels across the puberty, the
implementation of the prevention activities may start at
childhood.
Conclusions
In conclusion, the results from the present study suggest
that a single factor model underlies MS in Estonian and
Swedish children and adolescents and that this model
structure is stable from childhood to adolescence. The
clustering of cardiometabolic risk factors included in the
model, as well as the MS index itself, showed acceptable
indexes of tracking and predictability.
Additional material
Additional file 1: Factor loading and goodness-of-fit indexes for the
single-factor model for the metabolic syndrome, by sex and age
groups. Girls: n = 1087; c2 = 3.9, df = 2, p = 0.142; CFI = 0.99; and SRMR
= 0.016. Boys: n = 977; c2 = 13.4, df = 2, p = 0.001; CFI = 0.93; and SRMR
= 0.033. Nine years: n = 1005; c2 = 13.0, df = 2, p = 0.002; CFI = 0.95;
and SRMR = 0.030. Fifteen years: n = 1059; c2 = 16.4, df = 2, p = 0.001;
CFI = 0.91; and SRMR = 0.032. MAP: mean arterial pressure. Goodness-of-
fit indexes for the single-factor model for the metabolic syndrome, by
sex and age groups.
Additional file 2: Intraclass correlation coefficients between gender
and age standardized cardiometabolic risk variables and metabolic
syndrome index from childhood (9 year-old) to adolescence (15
year-old), by country. The European Youth Heart Study, 1998-2004.
Concordance between childhood and adolescence of the z scores of the
cardiometabolic risk variables measured by the intraclass correlation
coefficient.
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